Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC

NCT04611165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Nivolumab

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]